Prosecution Insights
Prosecution Insights
Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Centre Nationale De La Recherche Scientifique is managing 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are assigned to 2 distinct examiners, meaning each pending application is being reviewed by a different individual. This distribution requires the legal team to tailor their approach to 2 different examiner styles for the matters.
The 2 pending office actions are located within 2 distinct art units. This distribution indicates that the company's mechanical engineering innovations are being evaluated by 2 different technical groups within the patent office. Practitioners should be aware of potential differences in how these distinct art units apply examination guidelines to the applications.
COLLINS, SEAN W is the busiest examiner for this portfolio, holding 1 pending office action. Since COLLINS, SEAN W and the other distinct examiner each have 1 action, the workload is distributed across the examiner pool. Success in the 2 pending office actions will depend on addressing the specific requirements of both COLLINS, SEAN W and the other examiner across the 2 distinct art units in the Medical Devices & Mechanical Engineering field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLLINS, SEAN W | 1 | 74.7% | +26.7% |
| FRITCHMAN, REBECCA M | 1 | 45.7% | +35.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850367 | DEVICE AND METHOD FOR ASSISTANCE IN A PERCUTANEOUS TUMOUR ABLATION PROCEDURE | COLLINS, SEAN W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850367 | DEVICE AND METHOD FOR ASSISTANCE IN A PERCUTANEOUS TUMOUR ABLATION PROCEDURE | COLLINS, SEAN W | — |
| 17624793 | MICROFLUIDIC DEVICE COMPRISING A MICRODROP HAVING A SOL-GEL MATRIX | FRITCHMAN, REBECCA M | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18850367 | DEVICE AND METHOD FOR ASSISTANCE IN A PERCUTANEOUS TUMOUR ABLATION PROCEDURE | COLLINS, SEAN W | 3794 | §101§103§112 | Non-Final OA | — | Pending | Sep 24, 2024 |
| 17624793 | MICROFLUIDIC DEVICE COMPRISING A MICRODROP HAVING A SOL-GEL MATRIX | FRITCHMAN, REBECCA M | 1758 | §103 | Non-Final OA | — | Pending | Jan 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial